Fisher & Paykel Healthcare Corporation Limited announced that it has selected Charlotte Walshe to participate in the Future Directors programme, with effect from 1 January 2024. Ms Walshe has more than 20 years of experience across a range of sectors. This includes regulated global markets (healthcare, finance), high-tech manufacturing, export, technology and research institutes.

Ms Walshe has also held chief executive roles with Jade Software Corporation and medical device manufacturer and health informatics provider Dynamic Controls, and she has been a director and trustee of a number of government organisations, private companies and research institutions. She received a master of science in physics from the University of Canterbury, a bachelor of science (BSc) majoring in physics and mathematics, also from the University of Canterbury, and an Entrepreneurship Development Programme certificate from the Massachusetts Institute of Technology. Fisher & Paykel Healthcare's current Future Director, Tracey Barron, is completing her term with the company on 1 December 2023.